COMPENDIUM ON FUNCTIONAL MEDICINE - Flipbook - Page 375
[9] Cyrex Laboratories. Alzheimer's LINX™ cognitive immune
assessment. 2023.
[10] Vojdani A, Lambert J. The gut-brain axis: autoimmune and
neuroimmune disorders. Altern Ther Health Med. 2016;22(S3):31-46.
[11] Goedert M, et al. 100 years of Lewy pathology. Nat Rev
Neurol. 2013;9(1):13-24.
[12] Selkoe DJ. Alzheimer's disease: genes, proteins, and therapy.
Physiol Rev. 2001;81(2):741-766.
[13] Tuszynski MH, et al. A phase 1 clinical trial of nerve growth
factor gene therapy for Alzheimer disease. Nat Med.
2005;11(5):551-555.
[14] Gozes I. Specific protein biomarker patterns for Alzheimer's
disease: improved diagnostics in progress. EPMA J.
2017;8(3):255-259.
[15] Kelly JR, et al. Breaking down the barriers: the gut microbiome,
intestinal permeability, and stress-related psychiatric disorders.
Front Cell Neurosci. 2015;9:392.
[16] Fülling C, et al. The gut microbiota and the
brain-gut-microbiota axis in neuropsychiatric disorders:
pathophysiological mechanisms and novel treatments. Nutrients.
2019;11(12).
[17] Dominy SS, et al. Porphyromonas gingivalis in Alzheimer's
disease brains: evidence for disease causation and treatment with
small-molecule inhibitors. Sci Adv. 2019;5(1).
[18] Itzhaki RF, et al. Microbes and Alzheimer's disease. J
Alzheimers Dis. 2016;51(4):979-984.
[19] Chin-Chan M, et al. Environmental pollutants as risk factors for
neurodegenerative disorders: Alzheimer and Parkinson diseases.
Front Cell Neurosci. 2015;9:124.
375
